Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Portman Ridge Finance Surprises Investors with Strong Q4 Earnings Despite Revenue Decline

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Investings on laptop and finances
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Portman Ridge Finance (NASDAQ: PTMN) surprised investors with its Q4 earnings report on March 13, 2024, surpassing expectations by 51.0% with an EPS of $1.19, well above the estimated $0.79. Despite this positive news, the company experienced a decrease in revenue of $800 thousand compared to the same period last year.

Looking back at previous quarters, Portman Ridge Finance had a mixed performance. In the last quarter, the company fell short on EPS by $0.03, resulting in a 2.0% decline in share price the following day. Here’s a breakdown of the company’s past earnings:

– Q3 2023: EPS Estimate $0.78, EPS Actual $0.75, Revenue Estimate $18.98M, Revenue Actual $18.57M
– Q2 2023: EPS Estimate $0.78, EPS Actual $0.83, Revenue Estimate $18.80M, Revenue Actual $19.63M
– Q1 2023: EPS Estimate $0.76, EPS Actual $0.89, Revenue Estimate $18.78M, Revenue Actual $20.33M
– Q4 2022: EPS Estimate $0.76, EPS Actual $0.74, Revenue Estimate $17.79M, Revenue Actual $18.60M

For more detailed information on Portman Ridge Finance’s earnings announcements, interested parties can consult their earnings calendar.

This data was gathered from a variety of sources, including press releases and financial news articles pertaining to Portman Ridge Finance.

PTMN Stock Analysis: Positive Momentum and Potential Growth Ahead

On March 13, 2024, PTMN stock closed at $18.93, representing a slight increase of $0.03 or 0.13% since the previous market close. After the market closed, PTMN rose by $0.32 in after-hours trading, solidifying the positive momentum seen throughout the day. Investors may be noting PTMN’s steady performance and potential for growth. Trading near its 200-day simple moving average suggests the stock may have found support, indicating a potential upward trend in the future. It will be interesting to see how PTMN continues to perform and whether it can maintain its positive momentum. Investors should conduct their own research and consider their risk tolerance before making investment decisions.

PTMN Stock Analysis: Mixed Performances and Positive Signs of Improvement in Financial Metrics

On March 13, 2024, PTMN stock experienced mixed performances based on the company’s financial data provided by CNN Money. The total revenue for the past year was $37.64 million, which marked a significant decrease of 50.36% compared to the previous year. However, the total revenue for the third quarter of the fiscal year was $16.88 million, showing a notable increase of 28.32% since the last quarter.

Similarly, the net income for the past year was reported at -$21.00 million, indicating a substantial decrease of 180.67% compared to the previous year. On the other hand, the net income for the third quarter of the fiscal year was $7.45 million, showcasing a significant increase of 339.08% since the last quarter.

Furthermore, the earnings per share (EPS) for the past year were -$2.18, reflecting a decrease of 171.48% compared to the previous year. In contrast, the EPS for the third quarter of the fiscal year was reported at $0.78, demonstrating a remarkable increase of 339.98% since the last quarter.

These financial metrics suggest that PTMN has been experiencing fluctuations in its financial performance over the past year. While the total revenue has decreased and the net income has been negative, there have been positive signs of improvement in the recent quarter. The significant increase in net income and EPS since the last quarter indicates that the company may be on a path towards recovery and growth.

Investors and analysts will likely closely monitor PTMN’s future financial reports to assess the company’s ability to sustain its positive momentum and drive profitability. It will be interesting to see how PTMN stock performs in the coming months as the company continues to navigate through the challenges and opportunities in the market.

Tags: PTMN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Blockchain Trading online

SentinelOne Forecasts Strong Revenue Growth for Fiscal Year 2025

Finance_Fiscal (2)

Citigroup Analyst Maintains Buy Rating and Raises Price Target for East West Bancorp

Finance_Financing

Analyst Outlook on Valley National Bank

Recommended

Gerresheimer Stock

Gerresheimer Shares Plunge Amid Deepening Crisis

4 months ago
Alphabet Stock

Regulatory Pressure Mounts on Alphabet as UK Designates Search Dominance

4 months ago
Technology Data analytics stock Trading (1)

Revolutionizing Ad Monetization Brightcove and Google Ad Manager Join Forces

2 years ago
MMP stock news

Yousif Capital Management Reduces Holdings in Alarm.com, Inc. – Analyzing Impact on Future Prospects

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

Solana Faces Billions in Potential Token Supply Releases

CureVac Delisted Following BioNTech Acquisition Completion

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Trending

CrowdStrike Stock
Analysis

CrowdStrike Shares Face Headwinds Amid Mixed Signals

by Andreas Sommer
February 5, 2026
0

The investment case for cybersecurity leader CrowdStrike is currently being shaped by conflicting developments. Positive legal news...

NCR Stock

NCR Voyix Charts a Course Toward Cloud-Centric Growth

February 5, 2026
Rolls Royce Stock

Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

February 5, 2026
Viking Therapeutics Stock

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

February 5, 2026
Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CrowdStrike Shares Face Headwinds Amid Mixed Signals
  • NCR Voyix Charts a Course Toward Cloud-Centric Growth
  • Rolls-Royce Shares: A Pivotal Period for Growth and Diversification

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com